Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 30, 2022 09:28 ET | Source: OncoTEX

OncoTEX Receives Notice of Allowance for Patent in Korea Regarding Ovarian Cancer-Fighting Drug OxaliTEX

Notice of allowance of OxaliTEX patent in Korea adds further global protection OxaliTEX has already been granted patent protection in the U.S., Australia, Singapore, Mexico and Israel AUSTIN,...
March 14, 2022 09:19 ET | Source: OncoTEX

OncoTEX Issued New U.S. Patent for Ovarian Cancer-Fighting Drug OxaliTEX

AUSTIN, Texas, March 14, 2022 (GLOBE NEWSWIRE) -- OncoTEX Inc., an oncology company developing first-in-class cancer pharmaceuticals that are tumor localizing, exhibit low side effects, target both...
February 01, 2022 09:15 ET | Source: OncoTEX

Chemical Society Reviews Journal Explores How OncoTEX’s Gold-Based Compounds Can Activate the Immune System to Fight Cancer

AUSTIN, Texas, Feb. 01, 2022 (GLOBE NEWSWIRE) -- OncoTEX Inc., an oncology company developing first in class cancer therapeutics that are well-tolerated, MRI-detectable, and target drug-sensitive...